- ORCID iD
- 0000-0003-3821-0620
Show
Sort by
-
Optimization of VHH-based chimeric antigen receptor T cells for the treatment of solid and liquid malignancies
(2023) -
- Journal Article
- A1
- open access
The Wiskott–Aldrich syndrome protein is required for positive selection during T-cell lineage differentiation
-
- Miscellaneous
- open access
Knocking out CD70 rescues CD70-specific nanoCAR T cells from antigen induced exhaustion
-
- Journal Article
- A1
- open access
Single-cell profiling identifies a novel human polyclonal unconventional T cell lineage
-
- Journal Article
- A1
- open access
Delivery of macromolecules in unstimulated T cells by photoporation with polydopamine nanoparticles
-
- Journal Article
- A1
- open access
The transcription factor RUNX2 drives the generation of human NK cells and promotes tissue residency
-
- Journal Article
- A1
- open access
Small-scale manufacturing of neoantigen-encoding messenger RNA for early-phase clinical trials
-
- Journal Article
- A1
- open access
In vitro OP9-DL1 co-culture and subsequent maturation in the presence of IL-21 generates tumor antigen-specific T cells with a favorable less-differentiated phenotype and enhanced functionality
-
- Journal Article
- A1
- open access
Photothermal nanofibres enable safe engineering of therapeutic cells
-
- Journal Article
- A1
- open access
Human thymic CD10+ PD-1+ intraepithelial lymphocyte precursors acquire interleukin-15 responsiveness at the CD1a– CD95+ CD28– CCR7– developmental stage
-
- Journal Article
- A1
- open access
Intracellular delivery of mRNA in adherent and suspension cells by vapor nanobubble photoporation
-
- Journal Article
- A1
- open access
Rapid and effective generation of nanobody based CARs using PCR and Gibson Assembly
-
- Journal Article
- A1
- open access
T-cells with a single tumor antigen-specific T-cell receptor can be generated in vitro from clinically relevant stem cell sources
-
- Journal Article
- A1
- open access
Safe eradication of large established tumors using neovasculature-targeted tumor necrosis factor-based therapies
-
- Journal Article
- A1
- open access
TARP is an immunotherapeutic target in acute myeloid leukemia expressed in the leukemic stem cell compartment
-
- Conference Paper
- C3
- open access
TARP as immunotherapeutic target in AML expressed in the LSC compartment
-
- Journal Article
- A1
- open access
Nanobody based dual specific CARs
-
The checkpoint for agonist selection precedes conventional selection in human thymus
-
- Journal Article
- A1
- open access
Antigen receptor-redirected T cells derived from hematopoietic precursor cells lack expression of the endogenous TCR/CD3 receptor and exhibit specific antitumor capacities